221 related articles for article (PubMed ID: 33807275)
1. High Mobility Group Box 1 Promotes Lung Cancer Cell Migration and Motility via Regulation of Dynamin-Related Protein 1.
Liu WL; Li CY; Cheng WC; Chang CY; Chen YH; Lu CY; Wang SC; Liu YR; Cheng MH; Chong IW; Liu PL
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807275
[TBL] [Abstract][Full Text] [Related]
2. ERK/Drp1-dependent mitochondrial fission contributes to HMGB1-induced autophagy in pulmonary arterial hypertension.
Feng W; Wang J; Yan X; Zhang Q; Chai L; Wang Q; Shi W; Chen Y; Liu J; Qu Z; Li S; Xie X; Li M
Cell Prolif; 2021 Jun; 54(6):e13048. PubMed ID: 33948998
[TBL] [Abstract][Full Text] [Related]
3. Recombinant High-Mobility Group Box 1 (rHMGB1) Promotes NRF2-Independent Mitochondrial Fusion through CXCR4/PSMB5-Mediated Drp1 Degradation in Endothelial Cells.
Zhang S; Feng F; Dai J; Li J; Bu X; Xie X
Oxid Med Cell Longev; 2021; 2021():9993240. PubMed ID: 34394840
[TBL] [Abstract][Full Text] [Related]
4. YAP Inhibits the Apoptosis and Migration of Human Rectal Cancer Cells via Suppression of JNK-Drp1-Mitochondrial Fission-HtrA2/Omi Pathways.
Li H; He F; Zhao X; Zhang Y; Chu X; Hua C; Qu Y; Duan Y; Ming L
Cell Physiol Biochem; 2017; 44(5):2073-2089. PubMed ID: 29241219
[TBL] [Abstract][Full Text] [Related]
5. Actin bundling by dynamin 2 and cortactin is implicated in cell migration by stabilizing filopodia in human non-small cell lung carcinoma cells.
Yamada H; Takeda T; Michiue H; Abe T; Takei K
Int J Oncol; 2016 Sep; 49(3):877-86. PubMed ID: 27572123
[TBL] [Abstract][Full Text] [Related]
6. HMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancer.
Huang CY; Chiang SF; Chen WT; Ke TW; Chen TW; You YS; Lin CY; Chao KSC; Huang CY
Cell Death Dis; 2018 Sep; 9(10):1004. PubMed ID: 30258050
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.
Liu PL; Liu WL; Chang JM; Chen YH; Liu YP; Kuo HF; Hsieh CC; Ding YS; Chen WW; Chong IW
PLoS One; 2017; 12(7):e0180844. PubMed ID: 28727734
[TBL] [Abstract][Full Text] [Related]
8. Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling.
Ren Y; Cao L; Wang L; Zheng S; Zhang Q; Guo X; Li X; Chen M; Wu X; Furlong F; Meng Z; Xu K
Cell Death Dis; 2021 Sep; 12(10):858. PubMed ID: 34552063
[TBL] [Abstract][Full Text] [Related]
9. Localization of dynamin-related protein 1 and its potential role in lamellipodia formation.
Jo Y; Cho HM; Sun W; Ryu JR
Histochem Cell Biol; 2017 Jul; 148(1):13-20. PubMed ID: 28314909
[TBL] [Abstract][Full Text] [Related]
10. SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer.
Jiao P; Hou J; Yao M; Wu J; Ren G
Biomed Pharmacother; 2019 Sep; 117():109164. PubMed ID: 31252267
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dynamics regulates migration and invasion of breast cancer cells.
Zhao J; Zhang J; Yu M; Xie Y; Huang Y; Wolff DW; Abel PW; Tu Y
Oncogene; 2013 Oct; 32(40):4814-24. PubMed ID: 23128392
[TBL] [Abstract][Full Text] [Related]
12. Luteolin enhances TRAIL sensitivity in non-small cell lung cancer cells through increasing DR5 expression and Drp1-mediated mitochondrial fission.
Wu B; Xiong J; Zhou Y; Wu Y; Song Y; Wang N; Chen L; Zhang J
Arch Biochem Biophys; 2020 Oct; 692():108539. PubMed ID: 32777260
[TBL] [Abstract][Full Text] [Related]
13. An epigenetic increase in mitochondrial fission by MiD49 and MiD51 regulates the cell cycle in cancer: Diagnostic and therapeutic implications.
Dasgupta A; Chen KH; Wu D; Hoskin V; Mewburn J; Lima PDA; Parlow LRG; Hindmarch CCT; Martin A; Sykes EA; Tayade C; Lightbody ED; Madarnas Y; SenGupta SK; Elliott BE; Nicol CJB; Archer SL
FASEB J; 2020 Apr; 34(4):5106-5127. PubMed ID: 32068312
[TBL] [Abstract][Full Text] [Related]
14. High mobility group Box-1 inhibits cancer cell motility and metastasis by suppressing activation of transcription factor CREB and nWASP expression.
Zuo Z; Che X; Wang Y; Li B; Li J; Dai W; Lin CP; Huang C
Oncotarget; 2014 Sep; 5(17):7458-70. PubMed ID: 25277185
[TBL] [Abstract][Full Text] [Related]
15. High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness.
Liu PL; Tsai JR; Hwang JJ; Chou SH; Cheng YJ; Lin FY; Chen YL; Hung CY; Chen WC; Chen YH; Chong IW
Am J Respir Cell Mol Biol; 2010 Nov; 43(5):530-8. PubMed ID: 19933377
[TBL] [Abstract][Full Text] [Related]
16. LncRNA DSCAM-AS1 promotes non-small cell lung cancer progression via regulating miR-577/HMGB1 axis.
Qiu Z; Pan XX; You DY
Neoplasma; 2020 Jul; 67(4):871-879. PubMed ID: 32386483
[TBL] [Abstract][Full Text] [Related]
17. QiDongNing induces lung cancer cell apoptosis via triggering P53/DRP1-mediated mitochondrial fission.
Ding R; Wang Y; Xu L; Sang S; Wu G; Yang W; Zhang Y; Wang C; Qi A; Xie H; Liu Y; Dai A; Jiao L
J Cell Mol Med; 2024 May; 28(9):e18353. PubMed ID: 38682742
[TBL] [Abstract][Full Text] [Related]
18. MiRNA-218, a new regulator of HMGB1, suppresses cell migration and invasion in non-small cell lung cancer.
Zhang C; Ge S; Hu C; Yang N; Zhang J
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1055-61. PubMed ID: 24247270
[TBL] [Abstract][Full Text] [Related]
19. SIRT4 inhibits malignancy progression of NSCLCs, through mitochondrial dynamics mediated by the ERK-Drp1 pathway.
Fu L; Dong Q; He J; Wang X; Xing J; Wang E; Qiu X; Li Q
Oncogene; 2017 May; 36(19):2724-2736. PubMed ID: 27941873
[TBL] [Abstract][Full Text] [Related]
20. Elevated HMGB1 promotes the malignant progression and contributes to cisplatin resistance of non-small cell lung cancer.
Ma Y; Feng Q; Han B; Yu R; Jin Z
Hereditas; 2023 Jul; 160(1):33. PubMed ID: 37518006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
